Lung Disease, Chronic Obstructive

1

Review clinical trials related to Lung Disease, Chronic Obstructive. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The REVIVE Pivotal Study

The goal of this study is to test whether a new treatment called the Ryme Medical Targeted Lung Denervation (TLD) Catheter is safe and effective for people with moderate to severe chronic obstructive pulmonary disease (COPD). The main questions it aims to answer are: 1. Does the TLD Catheter improve symptoms in people with COPD? 2. Is the TLD Catheter safe ? Researchers will compare the group receiving the TLD treatment to the group receiving a sham procedure to see if the treatment improves quality of life. Participants will: 1. Be randomly assigned to receive either the TLD treatment or a sham procedure. 2. Undergo the assigned procedure in a hospital setting. 3. Attend follow-up visits for health checks and breathing tests.

Participants needed: 300
Trial details
Age: 40-80Biological sex: AllType: InterventionalSponsor: Ryme Medical, Inc.Updated: May 5, 2026
Eligibility criteria

Symptomatic chronic obstructive pulmonary disease [+3]

Prior lung intervention with device in place [+3]